DXL Board Urges 'AGAINST' FullBeauty Merger as Bank of America Pulls Financing
DXLG is trading near its 52-week low of $0.43 (7.0% above the low).
Summary
DXL's board formally recommends voting AGAINST the FullBeauty merger it is contractually obligated to submit, citing FBB's deteriorating finances and Bank of America's withdrawal of the Combined ABL Facility. The board simultaneously urges approval of a reverse stock split and equity plan expansion to preserve Nasdaq listing.
Key Events · M&A and Partnerships · DXLG
-
Board Recommends AGAINST Merger
The DXL board unanimously withdrew its prior recommendation and now urges stockholders to vote AGAINST the issuance proposal for the FullBeauty Brands merger, citing FBB's declining operating performance, increased indebtedness, and potential negative equity value.
-
Bank of America Pulls Financing
Bank of America notified DXL and FBB on September 25, 2026 that it will not extend commitments beyond October 14, 2026 and will not underwrite the Combined ABL Facility, leaving the combined company without committed financing and creating significant liquidity risk.
-
Private Placement Amended to $107M
The private placement was amended on August 21, 2026 to increase the aggregate purchase price from approximately $92 million to $107 million via an additional $15 million debt-for-equity conversion by Charlesbank and Deutsche Bank affiliates, without additional dilution to DXL stockholders.
-
Reverse Stock Split Proposed
The board recommends a reverse stock split at a ratio between 1-for-2 and 1-for-30 to regain Nasdaq compliance, with the stock at $0.46 against a $1.00 minimum bid requirement and a February 1, 2027 deadline.
Analysis · DXLG · Trade & Services
The DXL board has formally withdrawn its recommendation for the FullBeauty Brands merger and is asking stockholders to vote against the share issuance proposal, while simultaneously recommending approval of a reverse stock split and an equity plan expansion. The board's reversal is driven by FBB's deteriorating financial condition, increased indebtedness, and — critically — Bank of America's September 25, 2026 decision not to underwrite the Combined ABL Facility, which leaves the combined company without committed financing. The board now believes FBB may have negative equity value and that the merger would be substantially economically dilutive to DXL stockholders. Despite the board's recommendation, binding voting agreements covering 20.78% of outstanding shares (including 10.38% held by PLP) obligate those holders to vote FOR the issuance proposal, creating a real possibility the merger is approved against the board's wishes. The reverse stock split proposal (1-for-2 to 1-for-30) is framed as imperative for Nasdaq compliance regardless of the merger outcome, with the stock trading at $0.46 against a $1.00 minimum bid requirement and a February 1, 2027 compliance deadline.
How filings like this one have moved
In the 30 days to Oct 2, 2026, 40.6% of the 330 measured filings Wiseek scored 9 moved their stock by 5% or more by the next session's close. The median move was -0.38%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DXLG was trading at $0.46 on NASDAQ in the Trade & Services sector, with a market capitalization of approximately $25.5M. The 52-week trading range was $0.43 to $1.58. This filing was assessed with negative market sentiment and an importance score of 9 out of 10.